1. Home
  2. RSSS vs AFMD Comparison

RSSS vs AFMD Comparison

Compare RSSS & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RSSS
  • AFMD
  • Stock Information
  • Founded
  • RSSS 2006
  • AFMD 2000
  • Country
  • RSSS United States
  • AFMD Germany
  • Employees
  • RSSS N/A
  • AFMD N/A
  • Industry
  • RSSS Business Services
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • RSSS Consumer Discretionary
  • AFMD Health Care
  • Exchange
  • RSSS Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • RSSS 86.4M
  • AFMD 53.3M
  • IPO Year
  • RSSS N/A
  • AFMD 2014
  • Fundamental
  • Price
  • RSSS $2.68
  • AFMD $3.36
  • Analyst Decision
  • RSSS Strong Buy
  • AFMD Strong Buy
  • Analyst Count
  • RSSS 1
  • AFMD 5
  • Target Price
  • RSSS $6.00
  • AFMD $16.25
  • AVG Volume (30 Days)
  • RSSS 30.4K
  • AFMD 80.0K
  • Earning Date
  • RSSS 11-07-2024
  • AFMD 11-12-2024
  • Dividend Yield
  • RSSS N/A
  • AFMD N/A
  • EPS Growth
  • RSSS N/A
  • AFMD N/A
  • EPS
  • RSSS N/A
  • AFMD N/A
  • Revenue
  • RSSS $44,623,899.00
  • AFMD $7,959,927.00
  • Revenue This Year
  • RSSS $13.76
  • AFMD N/A
  • Revenue Next Year
  • RSSS $9.92
  • AFMD $48.98
  • P/E Ratio
  • RSSS N/A
  • AFMD N/A
  • Revenue Growth
  • RSSS 18.35
  • AFMD N/A
  • 52 Week Low
  • RSSS $2.21
  • AFMD $2.92
  • 52 Week High
  • RSSS $3.50
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • RSSS 50.43
  • AFMD 44.84
  • Support Level
  • RSSS $2.55
  • AFMD $3.28
  • Resistance Level
  • RSSS $2.75
  • AFMD $3.51
  • Average True Range (ATR)
  • RSSS 0.10
  • AFMD 0.17
  • MACD
  • RSSS -0.00
  • AFMD 0.04
  • Stochastic Oscillator
  • RSSS 53.57
  • AFMD 55.79

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: